Nav: Home

Condom use among high school girls using long-acting contraception

March 14, 2016

High school girls who used intrauterine devices and implants for long-acting reversible contraception were less likely to also use condoms compared with girls who used oral contraceptives, according to an article published online by JAMA Pediatrics.

Long-acting reversible contraception (LARC) is a promising strategy to reduce unintended pregnancies in teens. But LARC and other contraceptive methods, including oral contraceptives, don't protect against sexually transmitted infections (STIs) and nearly half of all new STIs occur among young people in their teens and 20s. Guidelines recommend contraception to avoid pregnancy and a condom to prevent STIs, including the human immunodeficiency virus (HIV), for sexually active couples. However, such dual use is uncommon among adolescents.

Riley J. Steiner, M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and coauthors compared condom use between sexually active high school girls using LARC and users of other contraceptive methods. The authors used data from the 2013 national Youth Risk Behavior Survey of high schools students.

The study included 2,288 sexually active girls of whom almost 57 percent were white and about one-third were high school seniors. Among the girls: 1.8 percent used LARC; 5.7 percent used Depo-Provera injection, patch or ring; 22.4 percent used oral contraceptives; 40.8 percent used condoms; 11.8 percent used withdrawal or other method; 15.7 percent used no contraception; and 1.9 percent weren't sure. Not using a contraceptive method was most common among Hispanic (23.7 percent) and black (21.2 percent) sexually active female students.

The authors report that LARC users were more than 60 percent less likely to use condoms compared with girls who used oral contraceptives. There were no differences in condom use between LARC users and Depo-Provera injection, patch or ring users. LARC users also were more than twice as likely to have two or more recent sexual partners compared with users of oral contraception and Depo-Provera injection, patch or ring, the results suggest.

Limitations to the study include self-reported data and behaviors that may have been inaccurately reported.

"There is a clear need for a concerted effort to improve condom use among adolescent LARC users to prevent STIs, particularly as adolescent LARC use increases," the study concludes.
-end-
(JAMA Pediatr. Published online March 14, 2016. doi:10.1001/jamapediatrics.2016.0007. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The article includes funding/support disclosures. Please see article for additional information, including other authors, author contributions and affiliations, etc.

Editorial: We Need a Better Message

"We need to work on crafting a clear message about pregnancy prevention and STI prevention. Withholding LARC -- the most effective methods of reversible contraception -- owing to concerns about the unintended consequence of decreased condom use is not the answer. Condoms still need to be part of the conversation because STIs are common in the adolescent population. ... Dual protection for sexually active adolescents should be encouraged so that adolescents are not exposed to the risk of pregnancy or the risk of STIs as a result of selecting condom use vs. effective contraception use. Condoms and LARC complement each other. We need to get the message right," write Julia Potter, M.D., of the Boston Medical Center, Massachusetts, and Karen Soren, M.D., of the Columbia University Medical Center, New York, in a related editorial.

(JAMA Pediatr. Published online March 14, 2016. doi:10.1001/jamapediatrics.2016.0141. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see article for additional information, including other authors, author contributions and affiliations, etc.

Media Advisory: To contact corresponding author Riley J. Steiner, M.P.H., call Brian Katzowitz at 404-639-1470 or email bkatzowitz@cdc.gov. To contact editorial corresponding author Julia Potter, M.D., call Jenny Eriksen Leary at 617-638-6841 or email jenny.eriksen@bmc.org.

The JAMA Network Journals

Related Contraception Articles:

Experiences of undesired effects of hormonal contraception
A study of women who experienced mental ill-health from a hormonal contraception indicates they value their mental well-being higher than a satisfactory sex life.
Changes to Title X mean contraception access for teens could worsen nationwide, study shows
Texas teens lost access to confidential family planning services due to family planning budget cuts and loss of Title X funds, says a new study led by the University of Colorado College of Nursing just published in the Journal of Adolescent Health.
Long-acting contraception has proven highly effective but is restricted by some hospitals
Long-acting reversible contraceptives like intrauterine implants have greatly reduced unintended pregnancies and abortions, but government protections allowing religious hospitals to restrict care are limiting access to health care consumers, according to an expert at the University of Colorado Anschutz Medical Campus.
Women with a low desire to avoid pregnancy still use contraception
A new study challenges assumptions that women with the highest preference against pregnancy use more effective contraceptive methods and that women who might welcome pregnancy do not use contraception.
Study shows cost savings from same-day long-acting reversible contraception
According to a new study by Indiana University School of Medicine doctors, providing adolescents seeking birth control the ability to obtain a long-acting reversible contraceptive on the same day as their clinic visit could lead to significant cost savings for insurance providers.
BU researcher asks, 'is it time for another contraception revolution?'
In an effort to protect the planet and preserve its natural treasures for future generations, another contraception revolution that provides options for populations not currently being served by modern contraception may be the answer according to a Perspective in this week's New England Journal of Medicine.
Access to contraception not 'silver bullet' to stem population growth in Africa
The population of sub-Saharan Africa is set to double by 2050, yet a new study challenges a common misconception that this is caused solely by inadequate family planning.
The Lancet: First randomised trial finds no substantial difference in risk of acquiring HIV for three different forms of contraception
A randomised trial of more than 7,800 African women found that a type of contraceptive injection (intramuscular depot medroxyprogesterone acetate -- DMPA-IM) posed no substantially increased risk of HIV acquisition when compared with a copper intrauterine device (IUD) and a levonorgestrel (LNG) implant.
Demand for long-acting contraception rose sharply after 2016 election
A new, robust study conducted by investigators at Brigham and Women's Hospital finds that rates of long-acting, reversible contraception went up by 21.6 percent in the 30 days after the presidential election compared to rates at the same time of year in 2015.
Study shows low-income women in Texas are not getting contraception after childbirth
The study shows that two-thirds of women did not receive their desired contraception at the six-week postpartum visit, increasing risk of unintended pregnancy.
More Contraception News and Contraception Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.